Citius Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Citius Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Citius Pharmaceuticals Inc
Rating: 1.40283325
Author: Trendlyne DVM scores

about

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products...

0.58 0.00 (0.00%)

73.52% Fall from 52W High

43,007.0

XNAS Volume

XNAS 22 Sep, 2026 10:39 AM (EDT)

Not Eligible

Expensive Valuation

26.3 / 100

Technically Bearish

29.8 / 100

No estimates available

Citius Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Citius Pharma Inc Live Stock Price Today, Share Analysis and Chart

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products...

73.52% Fall from 52W High

SWOT Analysis

Citius Pharma Inc Live Price Chart

Citius Pharma Inc Live Price Chart